Tenet Healthcare (THC1) Stock Forecast & Price Target
2 Followers
THC1 Analyst Ratings
Strong Buy
13Buy2Hold0Sell
Based on 15 analysts giving stock ratings to Tenet Healthcare in the past 3 months
THC1 Stock 12 Month Forecast
Average Price Target
EUR 271.58▲(5.26% Upside)Based on 15 Wall Street analysts offering 12 month price targets for Tenet Healthcare in the last 3 months. The average price target is EUR 271.58 with a high forecast of EUR 303.88 and a low forecast of EUR 235.46. The average price target represents a 5.26% change from the last price of EUR 258.00.
Past 12 Months12 Month ForecastJan2026Oct2026
HighEUR 303.88
AverageEUR 271.58
LowEUR 235.46
Highest Price TargetHighestEUR 303.88Average Price TargetEUR 271.58Lowest Price TargetLowestEUR 235.46
Detailed List of Analyst Forecasts
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Kevin Fischbeck | Bank of America Securities | ― | buy | ― | Reiterated | 11/05/26 | ||
| Andrew Mok CFA | Barclays | EUR 263.90 | buy | 2.29%Upside | Reiterated | 11/04/26 | ||
| Matthew Gillmor CFA | KeyBanc | EUR 239.91→EUR 266.56 | buy | 3.32%Upside | Reiterated | 11/03/26 | ||
| Stephen Baxter | Wells Fargo | EUR 249.68→EUR 285.22 | buy | 10.55%Upside | Reiterated | 11/02/26 | ||
| Ann Hynes | Mizuho Securities | EUR 257.68→EUR 271.00 | buy | 5.04%Upside | Reiterated | 11/02/26 | ||
| Ryan Langston | TD Cowen | EUR 233.69→EUR 268.34 | buy | 4.01%Upside | Reiterated | 11/02/26 | ||
| A.J. Rice | UBS | EUR 273.67→EUR 302.10 | buy | 17.09%Upside | Reiterated | 11/02/26 | ||
| Whit Mayo | Leerink Partners | EUR 274.56→EUR 303.88 | buy | 17.78%Upside | Reiterated | 11/02/26 | ||
| Ben Hendrix | RBC Capital | EUR 251.46→EUR 270.12 | buy | 4.70%Upside | Reiterated | 11/01/26 | ||
| Michael Ha | Robert W. Baird | EUR 248.79→EUR 253.23 | hold | -1.85%Downside | Reiterated | 10/30/26 | ||
| Craig Hettenbach | Morgan Stanley | EUR 243.46→EUR 263.90 | buy | 2.29%Upside | Reiterated | 10/30/26 | ||
| John Ransom | Raymond James | EUR 253.23→EUR 266.56 | buy | 3.32%Upside | Reiterated | 10/30/26 | ||
| Jason Cassorla | Guggenheim | EUR 272.78→EUR 271.89 | buy | 5.39%Upside | Reiterated | 10/29/26 | ||
| Sean Dodge | BMO Capital | EUR 239.91→EUR 235.46 | hold | -8.74%Downside | Assigned | 10/29/26 | ||
| Benjamin Rossi | J.P. Morgan | EUR 279.89 | buy | 8.48%Upside | Reiterated | 09/01/26 |
| Rating | Follow | Article | |||
|---|---|---|---|---|---|
| Kevin FischbeckBank of America Securities | BuyReiterated | 11/05/26 | ― | ||
| Andrew Mok CFABarclays | BuyReiteratedEUR 263.90 | 11/04/26 | 2.29%Upside | ||
| Matthew Gillmor CFAKeyBanc | BuyReiteratedEUR 239.91→EUR 266.56 | 11/03/26 | 3.32%Upside | ||
| Stephen BaxterWells Fargo | BuyReiteratedEUR 249.68→EUR 285.22 | 11/02/26 | 10.55%Upside | ||
| Ann HynesMizuho Securities | BuyReiteratedEUR 257.68→EUR 271.00 | 11/02/26 | 5.04%Upside | ||
| Ryan LangstonTD Cowen | BuyReiteratedEUR 233.69→EUR 268.34 | 11/02/26 | 4.01%Upside | ||
| A.J. RiceUBS | BuyReiteratedEUR 273.67→EUR 302.10 | 11/02/26 | 17.09%Upside | ||
| Whit MayoLeerink Partners | BuyReiteratedEUR 274.56→EUR 303.88 | 11/02/26 | 17.78%Upside | ||
| Ben HendrixRBC Capital | BuyReiteratedEUR 251.46→EUR 270.12 | 11/01/26 | 4.70%Upside | ||
| Michael HaRobert W. Baird | HoldReiteratedEUR 248.79→EUR 253.23 | 10/30/26 | -1.85%Downside | ||
| Craig HettenbachMorgan Stanley | BuyReiteratedEUR 243.46→EUR 263.90 | 10/30/26 | 2.29%Upside | ||
| John RansomRaymond James | BuyReiteratedEUR 253.23→EUR 266.56 | 10/30/26 | 3.32%Upside | ||
| Jason CassorlaGuggenheim | BuyReiteratedEUR 272.78→EUR 271.89 | 10/29/26 | 5.39%Upside | ||
| Sean DodgeBMO Capital | HoldAssignedEUR 239.91→EUR 235.46 | 10/29/26 | -8.74%Downside | ||
| Benjamin RossiJ.P. Morgan | BuyReiteratedEUR 279.89 | 09/01/26 | 8.48%Upside |
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Best Analysts Covering Tenet Healthcare
3 Months
Success Rate20/26 ratings generated profit
77%
Average Return
+10.07%
Copying Andrew Mok CFA's trades and holding each position for 3 Months would result in 76.92% of your transactions generating a profit, with an average return of +10.07% per trade.
1 Year
Success Rate14/15 ratings generated profit
93%
Average Return
+29.98%
Copying Sarah James's trades and holding each position for 1 Year would result in 93.33% of your transactions generating a profit, with an average return of +29.98% per trade.
2 Years
Success Rate28/28 ratings generated profit
100%
Average Return
+89.15%
Copying David S Macdonald's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +89.15% per trade.
THC1 Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 32 | 26 | 27 | 14 | 20 |
| Hold | 2 | 1 | 2 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 34 | 27 | 29 | 17 | 23 |
In the current month, THC1 has received 20 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. THC1 average Analyst price target in the past 3 months is 271.58.
THC1 Financial Forecast
HighEUR 5.41
ConsensusEUR 4.73
LowEUR 3.97
THC1 Earnings Forecast
Next quarter’s earnings estimate for THC1 is EUR 4.73 with a range of EUR 3.97 to EUR 5.41. The previous quarter’s EPS was EUR 5.90. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
HighEUR 5.31B
ConsensusEUR 5.05B
LowEUR 4.98B
THC1 Sales Forecast
Next quarter’s sales forecast for THC1 is EUR 5.05B with a range of EUR 4.98B to EUR 5.31B. The previous quarter’s sales results were EUR 5.00B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
THC1 Stock Forecast FAQ
What is DE:THC1’s average 12-month price target, according to analysts?
Based on analyst ratings, Tenet Healthcare’s 12-month average price target is €271.58.
What is DE:THC1’s upside potential, based on the analysts’ average price target?
Tenet Healthcare has 5.26% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Tenet Healthcare a Buy, Sell or Hold?
Tenet Healthcare has a consensus rating of Strong Buy, which is based on 13 buy ratings, 2 hold ratings and 0 sell ratings.
What is Tenet Healthcare’s share price target?
The average share price target for Tenet Healthcare is €271.58. This is based on 15 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is €303.88, and the lowest forecast is €235.46. The average share price target represents a 5.26% increase from the current price of €258.
What do analysts say about Tenet Healthcare?
Tenet Healthcare’s analyst rating consensus is a Strong Buy. This is based on the ratings of 15 Wall Street analysts.
How can I buy shares of Tenet Healthcare?
To buy shares of DE:THC1, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
